Search Results - "Zou, Macy"

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada by Skowronski, Danuta M, Setayeshgar, Solmaz, Zou, Macy, Prystajecky, Natalie, Tyson, John R, Galanis, Eleni, Naus, Monika, Patrick, David M, Sbihi, Hind, El Adam, Shiraz, Henry, Bonnie, Hoang, Linda M N, Sadarangani, Manish, Jassem, Agatha N, Krajden, Mel

“…Abstract Background Randomized-controlled trials of messenger RNA (mRNA) vaccine protection against severe acute respiratory syndrome coronavirus 2…”
Get full text

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV) by Skowronski, Danuta M, Sabaiduc, Suzana, Leir, Siobhan, Rose, Caren, Zou, Macy, Murti, Michelle, Dickinson, James A, Olsha, Romy, Gubbay, Jonathan B, Croxen, Matthew A, Charest, Hugues, Bastien, Nathalie, Li, Yan, Jassem, Agatha, Krajden, Mel, De Serres, Gaston

“…Introduction The Canadian Sentinel Practitioner Surveillance Network reports vaccine effectiveness (VE) for the 2018/19 influenza A(H3N2) epidemic. Aim To…”
Get full text

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020 by Skowronski, Danuta M, Zou, Macy, Sabaiduc, Suzana, Murti, Michelle, Olsha, Romy, Dickinson, James A, Gubbay, Jonathan B, Croxen, Matthew A, Charest, Hugues, Jassem, Agatha, Krajden, Mel, Bastien, Nathalie, Li, Yan, De Serres, Gaston

“…Interim results from Canada's Sentinel Practitioner Surveillance Network show that during a season characterised by early co-circulation of influenza A and B…”
Get full text

A Computerized Frailty Assessment Tool at Points-of-Care: Development of a Standalone Electronic Comprehensive Geriatric Assessment/Frailty Index (eFI-CGA) by Sepehri, Katayoun, Braley, McKenzie Sarah, Chinda, Betty, Zou, Macy, Tang, Brandon, Park, Grace, Garm, Antonina, McDermid, Robert, Rockwood, Kenneth, Song, Xiaowei

“…Frailty is characterized by loss of biological reserves and is associated with an increased risk of adverse health outcomes. Frailty can be operationalized…”
Get full text

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada by Skowronski, Danuta M, Febriani, Yossi, Ouakki, Manale, Setayeshgar, Solmaz, El Adam, Shiraz, Zou, Macy, Talbot, Denis, Prystajecky, Natalie, Tyson, John R, Gilca, Rodica, Brousseau, Nicholas, Deceuninck, Geneviève, Galanis, Eleni, Fjell, Chris D, Sbihi, Hind, Fortin, Elise, Barkati, Sapha, Sauvageau, Chantal, Naus, Monika, Patrick, David M, Henry, Bonnie, Hoang, Linda M N, De Wals, Philippe, Garenc, Christophe, Carignan, Alex, Drolet, Mélanie, Jassem, Agatha N, Sadarangani, Manish, Brisson, Marc, Krajden, Mel, De Serres, Gaston

“…The Canadian coronavirus disease 2019 (COVID-19) immunization strategy deferred second doses and allowed mixed schedules. We compared 2-dose vaccine…”
Get full text

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada by Skowronski, Danuta M, Leir, Siobhan, Sabaiduc, Suzana, Chambers, Catharine, Zou, Macy, Rose, Caren, Olsha, Romy, Dickinson, James A, Winter, Anne-Luise, Jassem, Agatha, Gubbay, Jonathan B, Drews, Steven J, Charest, Hugues, Chan, Tracy, Hickman, Rebecca, Bastien, Nathalie, Li, Yan, Krajden, Mel, De Serres, Gaston

“…Abstract Background The influenza A(H3N2) vaccine was updated from clade 3C.3a in 2015–2016 to 3C.2a for 2016–2017 and 2017–2018. Circulating 3C.2a viruses…”
Get full text

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 by Skowronski, Danuta M, Zou, Macy, Clarke, Quinten, Chambers, Catharine, Dickinson, James A, Sabaiduc, Suzana, Olsha, Romy, Gubbay, Jonathan B, Drews, Steven J, Charest, Hugues, Winter, Anne-Luise, Jassem, Agatha, Murti, Michelle, Krajden, Mel, De Serres, Gaston

“…Abstract Influenza vaccine effectiveness against influenza and noninfluenza respiratory viruses (NIRVs) was assessed by test-negative design using historic…”
Get full text

SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada by El Adam, Shiraz, Zou, Macy, Kim, Shinhye, Henry, Bonnie, Krajden, Mel, Skowronski, Danuta M

“…Abstract Background One- and two-dose mRNA vaccine effectiveness (VE) estimates against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection…”
Get full text

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada by Skowronski, Danuta M, Setayeshgar, Solmaz, Zou, Macy, Prystajecky, Natalie, Tyson, John R, Sbihi, Hind, Fjell, Chris D, Galanis, Eleni, Naus, Monika, Patrick, David M, El Adam, Shiraz, Ahmed, May A, Kim, Shinhye, Henry, Bonnie, Hoang, Linda M N, Sadarangani, Manish, Jassem, Agatha N, Krajden, Mel

“…Abstract Background In British Columbia, Canada, most adults 50–69 years old became eligible for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text

Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada by Skowronski, Danuta M, Febriani, Yossi, Ouakki, Manale, Setayeshgar, Solmaz, El Adam, Shiraz, Zou, Macy, Talbot, Denis, Prystajecky, Natalie, Tyson, John R, Gilca, Rodica, Brousseau, Nicholas, Deceuninck, Geneviève, Galanis, Eleni, Fjell, Chris D, Sbihi, Hind, Fortin, Elise, Barkati, Sapha, Sauvageau, Chantal, Naus, Monika, Patrick, David M, Henry, Bonnie, Hoang, Linda M N, De Wals, Philippe, Garenc, Christophe, Carignan, Alex, Drolet, Mélanie, Jassem, Agatha N, Sadarangani, Manish, Brisson, Marc, Krajden, Mel, De Serres, Gaston

Get full text

THE EFFECTS OF FRAILTY, POLYPHARMACY, AND COGNITION ON HEALTH OUTCOMES: A STUDY ON INTERRAI RESIDENTIAL CARE DATA by Zou, Macy, Kelly, Ronald, Chinda, Betty, Braley, Mckenzie, Zhang, Tony, Arvan, Tara, Mcdermid, Robert, Song, Xiaowei

“…Abstract Frailty Index (FI), polypharmacy and cognition status are significant health concerns in older adults. We conducted this study to investigate the…”
Get full text

THE ELECTRONIC FRAILTY INDEX BASED ON THE COMPREHENSIVE GERIATRIC ASSESSMENT: DEVELOPMENT AND TESTING by Chinda, Betty, Sepehri, Katayoun, Zou, Macy, Braley, Mckenzie, Garm, Antonina, Park, Grace, Rockwood, Kenneth, Song, Xiaowei

“…Abstract Frailty is characterized by loss of biological reserves across multiple systems and associated with increased risks of adverse outcomes. A Frailty…”
Get full text

Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including variants of concern: test-negative design, British Columbia, Canada by Skowronski, Danuta M, Setayeshgar, Solmaz, Zou, Macy, Prystajecky, Natalie, Tyson, John R, Sbihi, Hind, Fjell, Chris D, Galanis, Eleni, Naus, Monika, Patrick, David M, El Adam, Shiraz, Ahmed, May A, Kim, Shinhye, Henry, Bonnie, Hoang, Linda M N, Sadarangani, Manish, Jassem, Agatha N, Krajden, Mel

“…In British Columbia, Canada, most adults 50-69 years old became SARS-CoV-2 vaccine-eligible in April 2021, with ChAdOx1 restricted to ≥55-year-olds and second…”
Get full text